Wang Guorong
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients (NCT02572596) | Wang Guorong | 2013-01-01 |
Track Wang Guorong automatically
Every clearance here is in the API, with alerts when new ones post.